Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 193, Issue 2, 2014, Pages 555-563

  Simmons, Sarah B ^a   Liggitt, Denny ^a   Goverman, Joan M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FLOW CYTOMETRY; HISTOCHEMISTRY; IN VIVO STUDY; MICROENVIRONMENT; MOUSE; MULTIPLE SCLEROSIS; MYELITIS; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; TISSUE INJURY;

ANIMALS; BRAIN; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MYELITIS; NEUTROPHIL INFILTRATION; PEPTIDE FRAGMENTS; RATS; RECEPTORS, INTERFERON; RECEPTORS, INTERLEUKIN-17; RECEPTORS, INTERLEUKIN-8B;

EID: 84904246348     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400807     Document Type: Article

References (33)

1. Muller, D. M., M. P. Pender, and J. M. Greer. 2000. A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction. Acta Neuropathol. 100: 174-182. (Pubitemid 30456140)
2. Wensky, A. K., G. C. Furtado, M. C. Marcondes, S. Chen, D. Manfra, S. A. Lira, D. Zagzag, and J. J. Lafaille. 2005. IFN-g determines distinct clinical outcomes in autoimmune encephalomyelitis. J. Immunol. 174: 1416-1423.
3. Tsunoda, I., L. Q. Kuang, D. J. Theil, and R. S. Fujinami. 2000. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol. 10: 402-418. (Pubitemid 30431293)
4. Lees, J. R., P. T. Golumbek, J. Sim, D. Dorsey, and J. H. Russell. 2008. Regional CNS responses to IFN-g determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 205: 2633-2642.
5. Greer, J. M., R. A. Sobel, A. Sette, S. Southwood, M. B. Lees, and V. K. Kuchroo. 1996. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156: 371-379. (Pubitemid 26006985)
6. Storch, M. K., A. Stefferl, U. Brehm, R. Weissert, E. Wallström, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann. 1998. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8: 681-694. (Pubitemid 28460927)
7. Pöllinger, B., G. Krishnamoorthy, K. Berer, H. Lassmann, M. R. Bösl, R. Dunn, H. S. Domingues, A. Holz, F. C. Kurschus, and H. Wekerle. 2009. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 206: 1303-1316.
8. Abromson-Leeman, S., R. Bronson, Y. Luo, M. Berman, R. Leeman, J. Leeman, and M. Dorf. 2004. T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis. Am. J. Pathol. 165: 1519-1533. (Pubitemid 39435152)
9. Kroenke, M. A., S. W. Chensue, and B. M. Segal. 2010. EAE mediated by a non-IFN-γ/non-IL-17 pathway. Eur. J. Immunol. 40: 2340-2348.
10. H17 cells. Nat. Med. 14: 337-342.
11. 4 integrin expression during EAE. J. Exp. Med. 208: 2465-2476.
12. q mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J. Neuroimmunol. 111: 23-33.
13. Brabb, T., P. von Dassow, N. Ordonez, B. Schnabel, B. Duke, and J. Goverman. 2000. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J. Exp. Med. 192: 871-880.
14. Lee, S. Y., and J. M. Goverman. 2013. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells. J. Immunol. 190: 4991-4999.
15. Sadik, C. D., N. D. Kim, and A. D. Luster. 2011. Neutrophils cascading their way to inflammation. Trends Immunol. 32: 452-460.
16. Carter, S. L., M. Müller, P. M. Manders, and I. L. Campbell. 2007. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 55: 1728-1739. (Pubitemid 47612859)
17. Huang, D., Y. Han, M. R. Rani, A. Glabinski, C. Trebst, T. Sørensen, M. Tani, J.Wang, P. Chien, S. O'Bryan, et al. 2000. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol. Rev. 177: 52-67.
18. Gil, M. P., E. Bohn, A. K. O'Guin, C. V. Ramana, B. Levine, G. R. Stark, H. W. Virgin, and R. D. Schreiber. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA 98: 6680-6685. (Pubitemid 32538276)
19. +CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205: 811-823.
20. Tran, E. H., E. N. Prince, and T. Owens. 2000. IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164: 2759-2768. (Pubitemid 30115510)
21. Stoolman, J. S., P. C. Duncker, A. K. Huber, and B. M. Segal. 2014. Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis. J. Immunol. 193: 564-570.
22. Hofstetter, H. H., S. M. Ibrahim, D. Koczan, N. Kruse, A. Weishaupt, K. V. Toyka, and R. Gold. 2005. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237: 123-130. (Pubitemid 43117208)
23. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573. (Pubitemid 43939170)
24. Gonzalez-García, I., Y. Zhao, S. Ju, Q. Gu, L. Liu, J. K. Kolls, and B. Lu. 2009. IL-17 signaling-independent central nervous system autoimmunity is negatively regulated by TGF-β. J. Immunol. 182: 2665-2671.
25. Hu, Y., N. Ota, I. Peng, C. J. Refino, D. M. Danilenko, P. Caplazi, and W. Ouyang. 2010. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 184: 4307-4316.
26. Haak, S., A. L. Croxford, K. Kreymborg, F. L. Heppner, S. Pouly, B. Becher, and A. Waisman. 2009. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119: 61-69.
27. Kroenke, M. A., and B. M. Segal. 2011. IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway. Brain Behav. Immun. 25: 932-937.
28. Matusevicius, D., P. Kivisäkk, B. He, N. Kostulas, V. Ozenci, S. Fredrikson, and H. Link. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5: 101-104.
29. Bartosik-Psujek, H., and Z. Stelmasiak. 2005. The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease. Eur. J. Neurol. 12: 49-54.
30. Havrdová, E., A. Belova, A. Goloborodko, A. Tisserant, I. Jones, H. Garren, and D. Johns; AIN457 for MS Study Group. 2012. ECTRIMS abstract: Positive proof of concept of AIN457, an antibody against interleukin-17A, in relapsing-remitting multiple sclerosis. Mult. Scler. J. 18: S4 (Abstr.) 513.
31. Chabas, D., J. Ness, A. Belman, E. A. Yeh, N. Kuntz, M. P. Gorman, J. B. Strober, I. De Kouchkovsky, C. McCulloch, T. Chitnis, et al; US Network of Pediatric MS Centers of Excellence. 2010. Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology 74: 399-405.
32. Naegele, M., K. Tillack, S. Reinhardt, S. Schippling, R. Martin, and M. Sospedra. 2012. Neutrophils in multiple sclerosis are characterized by a primed phenotype. J. Neuroimmunol. 242: 60-71.
33. Openshaw, H., B. T. Lund, A. Kashyap, R. Atkinson, I. Sniecinski, L. P. Weiner, and S. Forman. 2000. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biol. Blood Marrow Transplant. 6: 563-575. Diseases Stroke